Objectives/Hypothesis: To determine if apnea-hypopnea index (AHI) and lowest oxygen saturation (LSAT) improve following isolated supraglottoplasty for laryngomalacia with obstructive sleep apnea (OSA) in children.
INTRODUCTION
Pediatric sleep disordered breathing is a common problem. An epidemiological systematic review and meta-analysis 1 estimated that the prevalence of pediatric snoring is 7.45% (95% confidence interval [CI], 5.75%-9.61% based on parent observations) and that the prevalence of pediatric obstructive sleep apnea (OSA) is 1% to 4%. Pediatric OSA severity is classified as: no OSA: apnea-hypopnea index (AHI) < 1; mild OSA: AHI 1 to < 5; moderate OSA: AHI 5 to < 10; and severe: AHI 10 events/hour. 2 In children, treatment options include adenotonsillectomy, 3 myofunctional therapy, 4 palate expansion, 5 and allergy management. The success rate for adenotonsillectomy normalizing AHI (< 1 event/ hour) was found to be between 59.8% and 82.9% based on two meta-analyses. 3, 6 There is a subset of children with OSA who additionally have laryngomalacia (a disorder in which supraglottic tissue collapses and subsequently obstructs normal airflow). The collapse of supraglottic structures can lead to inspiratory stridor, which may get worse a few months after birth. 7 Triggers for stridor include upper respiratory infections, feeding, crying, agitation, and the supine position. 7 In traditional (congenital) laryngomalacia, patients have symptoms during wakefulness and sleep; however, some patients have supraglottic collapse only during sleep, which we term sleep exclusive laryngomalacia. Typically, patients with congenital laryngomalacia present early given that there can be failure to thrive and significant respiratory distress at times with cyanosis, retractions, and/or witnessed apneic events. laryngomalacia has been described as occult laryngomalacia, 2 late-onset laryngomalacia, 9 state-dependent laryngomalacia, 10 and sleep-dependent laryngomalacia. 11 Sleep exclusive laryngomalacia patients can present in older children (2-18 years), has an estimated incidence of 3.9%, and can be diagnosed with drug-induced sleep endoscopy. 12 There have been studies reporting that supraglottoplasty has successfully treated or even cured OSA in patients with laryngomalacia; however, to our knowledge a systematic review of the literature with meta-analysis has not been performed. The primary objective was to determine whether the AHI and lowest oxygen saturation (LSAT) improve following isolated supraglottoplasty for both congenital and sleep exclusive laryngomalacia with obstructive sleep apnea in children. To complete the objective, a systematic review of the international literature was performed for polysomnography outcomes, as reported in children undergoing isolated supraglottoplasty as treatment for laryngomalacia with obstructive sleep apnea, and the data was used to perform a meta-analysis.
MATERIALS AND METHODS
The Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement was followed as much as possible during this study. 13 As a systematic review of publically available articles, this study is exempted from institutional review board review. 
Search Strategy

Study Selection
Study inclusion criteria were as follows: 1) patients: children (< 18 years [y]) who have either congenital or sleep exclusive laryngomalacia and OSA; 2) intervention: isolated supraglottoplasty; 3) comparison: quantitative data pre-and postsupraglottoplasty; 4) outcome: polysomnography variables, general outcomes, and complications; and 5) study design: all designs were included in both published and unpublished forms and in all languages. Exclusion criteria were 1) studies with additional surgeries performed (unless individual patient data was reported for those undergoing isolated supraglottoplasties), 2) studies with qualitative outcomes only, and 3) patients with central sleep apnea.
Supraglottoplasty Surgeries
Based on the studies in this systematic review, the different kinds of supraglottoplasty surgeries performed specifically include: 1) unilateral aryepiglottic fold division, 2) bilateral aryepiglottic fold division, 3) bilateral aryepiglottic fold division with unilateral removal of redundant arytenoid tissue, and 4) bilateral complete (bilateral aryepiglottic fold division and bilateral removal of redundant arytenoid tissues). In some patients, epiglottis surgery was also performed.
Study Quality Assessment
The National Institute for Health and Clinical Excellence (NICE) quality assessment tool 14 was used to assess the quality of each individual study because it allows for assessment even when studies are the same level of evidence.
Statistics
The null hypothesis was that there is no difference in polysomnography outcomes pre-and post-supraglottoplasty. The IBM Statistical Package for Social Sciences software version 20.0 (Armonk, NY) was used for analyses. For two-tailed paired t tests, a P value < 0.05 was considered statistically significant. The Cochrane Collaboration's Review Manager Software (REV-MAN) version 5.3 was used for the meta-analysis. REVMAN was used to calculate the mean differences (MD), standardized mean differences (SMD), and 95% CI. Cohen's guidelines 15 were used for interpreting the SMD magnitude of effect (absolute value: small 5 0.2, medium 5 0.5, and large 5 0.8). Inconsistency was evaluated with REVMAN's I 2 statistic, and the recommended cutoffs were followed (low inconsistency: 25%, moderate inconsistency: 50%, and high inconsistency: 75%). 16 Heterogeneity between studies was evaluated by the Cochran Q statistic (Q statistic), and a P value 0.10 was considered to be statistically significant heterogeneity. 17 If inconsistency and/or heterogeneity was present, REVMAN was used to perform a sensitivity analysis by removing one study at a time until inconsistency and/or heterogeneity no longer existed in order to identify which studies were the sources. If AHI and respiratory disturbance index (RDI) were reported in the study, the AHI was selected for statistical analysis. If RDI alone was reported in the study, the plan was to contact the authors to obtain the AHI. As recommended by the Cochrane Collaboration, a funnel plot assessment was performed if there were at least 10 studies evaluating any given variable. For individual patient data subanalyses, the standard pediatric OSA severity classification was used: no OSA: AHI < 1, mild OSA: AHI 1 to < 5, moderate OSA: AHI 5 to < 10, and severe: AHI 10 events/hour. 2 Authors were contacted for studies that did not report enough data for meta-analysis to determine whether additional patient data could be obtained, which would allow inclusion in the analysis.
RESULTS
The searches yielded 517 studies, which were screened; 54 studies were reviewed in the full-text version; and after reviewing the references, another three studies were potentially relevant and were also reviewed (57 total). 2, [7] [8] [9] [10] [11] [12] Thirteen studies met criteria for inclusion. Coauthor D.K.C. provided data from two studies (Chan (a) et al. 20 and Chan (b) et al. 2 ) that excluded any duplicate patients and allowed for both studies to be included in the meta-analysis. After review of all the articles, only one article (Valera et al. 60 ) reported the RDI exclusively; the corresponding author was contacted, and upon review of the raw data the AHI and RDI were found to be the same. The corresponding author for the study by Tholpady et al. 59 was contacted to confirm whether any of the patients undergoing supraglottoplasty also underwent tonsillectomy, and the author replied that the patients did not; therefore, the study data could be included in the meta-analysis. Drs. Zafereo and Pereira confirmed that they always divide the aryepiglottic folds bilaterally, and then in 60% of the children in this study performed the unilateral supraglottoplasty, after that which consists of unilateral excision of the cuneiform cartilages and redundant mucosa. The corresponding author from Digoy et al. 23 was contacted twice in an attempt to obtain individual patient data; however, the attempts were unsuccessful. Figure 1 summarizes the study selection.
Forty-four studies were excluded for the following reasons: the number of patients undergoing polysomnography pre-and postsupraglottoplasty was not provided 43 ; no quantitative data for polysomnograms was provided 12, 18, 21, 22, [24] [25] [26] 28, 29, [32] [33] [34] [35] [36] [37] [38] [39] 41, 42, [44] [45] [46] 49, 51, 53, 54, 56, 58, 61, 64, 66 ; only adults were included 19 ; procedure(s) were performed in addition to the supraglottoplasty with no stratification of data for those who underwent isolated supraglottplasty 27, 50, 63 ; only preoperative data was available 55 ; some children were sedated with choral hydrate 47 ; the postoperative data was only available for a fraction of patients 30 ; portable pulse-oximetry was used instead of formal polysomnography 31 ; or they were review articles. 40, 52, 62 Overall, there were a total of 138 patients (ages 1 month-12.6 years) with quantitative polysomnographic data who underwent isolated supraglottoplasty. Sixtyfour patients had sleep exclusive laryngomalacia, and 74 patients had congenital laryngomalacia.
Study Quality Assessment
Studies meeting criteria to be included in this review were case reports, case series studies, or casecontrol studies. The studies met three to six of the eight NICE quality-assessment tool criteria (see Table I ).
Sleep Exclusive Laryngomalacia
Apnea-Hypopnea Index. Polysomnography outcomes for isolated supraglottoplasty demonstrated that the AHI decreased from a mean (M) 6 standard deviation (SD) of 14.0 6 16.5 (95% CI 10.0, 18.0) to 3.3 6 4.0 (95% CI 2.4, 4.4) events/hour, see Table II . The MD was 10.7 events/hour (95% CI 214.9, 26.5). The relative reduction of the mean values was 76.4% (95% CI 53.6, 106.4%). A subanalysis using random effects modeling was performed for four studies (62 patients) in which M 6 SD were reported, and the AHI MD was 29.38 events/hour (95% CI 212.67, 26.10), overall effect Z 5 5.60, P value < 0.00001, Q statistic P value 5 0.68 (no heterogeneity), I 2 5 0% (no inconsistency). The AHI SMD was 20.99 (95% CI 21.37, 20.62) (large magnitude of effect), overall effect Z 5 5.17 P value < 0.00001, Q statistic P value 5 0.91 (no heterogeneity), I 2 5 0% (no inconsistency). Lowest Oxygen Saturation. The overall mean preand postsupraglottoplasty lowest oxygen saturation M 6 SD were 84.8% 6 8.4% (95% CI 82.8, 86.8) and 87.6% 6 4.4% (95% CI 86.6, 88.8) (see Table II ). A subanalysis with random effects modeling was performed for 62 patients in which M 6 SD were reported, the MD was 1.79 points (95% CI 20.37, 3.96), overall effect Z 5 1.62, P value 5 0.10; Q statistic P value 0.29 (no heterogeneity) I 2 5 19% (low inconsistency). The sensitivity analysis demonstrated that after removal of the study by Chan (a) et al. there was no heterogeneity (Q statistic P value 5 0.37) and no inconsistency (I 2 5 0%). The LSAT SMD was 0.40 (95% CI 0.04, 0.76) (small magnitude of effect), overall effect Z 5 2.20 P value 0.03, Q statistic P value 5 0.65 (no heterogeneity), and I 2 5 0% (no inconsistency).
Congenital Laryngomalacia
Apnea-Hypopnea Index. The AHI decreased from an M 6 SD of 20.4 6 23.9 (95% CI 12.8, 28.0) to 4.0 6 4.5 (95% CI 2.6, 5.4) events/hour (38 patients) (see Table  III ). The MD was 216.4 events/hour (95% CI 221.9, 210.9), and the relative reduction was 80.4% (95% CI 46.6, 107.4%). A subanalysis with random effects modeling was performed for the six studies (38 patients) in which M 6 SD were reported, and the AHI MD was 28.78 events/hour (95% CI 212.40, 25.17), overall effect Z 5 4.76, P value < 0.00001, Q statistic P value 5 0.19 (no heterogeneity), and I 2 5 33% (low inconsistency). The sensitivity analysis demonstrated that after removal of the study by O'Connor et al., 48 there was no heterogeneity (Q statistic P value 5 0.89) and no inconsistency (I 2 5 0%). The AHI SMD was 21.21 (95% CI 21.83, 20.59) (large magnitude of effect), overall effect Z 5 3.84, P value 0.0001, Q statistic P value 5 0.91 (no heterogeneity), and I 2 5 0% (no inconsistency). Lowest Oxygen Saturation. The overall mean pre-and postsupraglottoplasty lowest oxygen saturation was reported for 41 patients. The LSAT M 6 SD were 74.5 6 11.9% (95% CI 70.9, 78.1) and 88.4 6 6.6% (95% CI 86.4, 90.4) (see Table III ). A subanalysis with random effects modeling was performed for 41 patients in which M 6 SD were reported: the MD was 12.18 points (95% CI 4.02, 20.34), overall effect Z 5 2.93, P value 5 0.003; Q statistic P value 0.006 (significant heterogeneity), and I 2 5 76% (high inconsistency). A sensitivity analysis demonstrated that after removal of the data from the study by Li et al., 67 there was no heterogeneity (Q statistic P value 5 0.31) and low inconsistency (I 2 5 16%). The LSAT SMD was 1.31 (95% CI 0.32, 2.30) (large magnitude of effect), overall effect Z 5 2.60, P value 0.009, Q statistic P value 5 0.01 (significant heterogeneity), and I 2 5 73% (high inconsistency). The sensitivity analysis demonstrated that after removal of the study by Li et al.
there was no heterogeneity (Q statistic P value 5 0.32) and low inconsistency (I 2 5 12%). The overall MDs, SMDs with the magnitude of effect based on Cohen's guidelines for AHI and LSAT are presented in Table IV .
Individual Patient Data Analysis
Nine studies [9] [10] [11] 20, 48, 57, 59, 60, 65 provided individual patient data, whereas four studies did not. 2, 8, 23, 67 For patients with sleep exclusive laryngomalacia, cure (AHI < 1 event/hour) was observed in two out of 19 patients (10.5%). For patients with congenital laryngomalacia, cure was observed in 10 of 38 patients (26.5%).
Additional Outcomes
Studies reported several variables that improved after supraglottoplasty (see Table V ). Mase et al. reported that the patients had increased postoperative weight for length percentile. 11 Li et al., 67 Oomen and Modi, 10 and Chan et al. 2 reported that the patients had no stridor after surgery. Li et al. 67 and Chan et al. 2 reported no feeding difficulties postoperatively. With regard to levels of stridor improvement, Zafereo et al. 65 noted mild improvement in 10% of patients, significant improvement in 70%, and complete resolution in 20%.
Complications
Digoy et al. reported that three of 36 children had a postoperative increase in coughing and throat clearing, and one had dysphagia for greater than 6 months. 23 Powitzky et al. reported that one of 20 patients required a revision supraglottoplasty, whereas five required an adenotonsillectomy to alleviate their OSA. 8 O'Connor et al. reported that during surgery, one patient developed a collapse of a pulmonary lobe on the left side due to the endotracheal tube being in the right main bronchus. 48 In the study by Sesterhenn et al., a revision epiglottopexy was performed for suture dehiscence, and once the revision was performed the patient dramatically improved. 57 Four studies reported no significant or major complications (see Table V ).
DISCUSSION
There are five main findings from this study. First, this review has demonstrated that sleep exclusive laryngomalacia and congenital laryngomalacia have different presentations and are comprised of distinct groups of patients. In the currently published studies, all children with sleep exclusive laryngomalacia have been diagnosed via drug-induced sleep endoscopy (DISE). Fortyeight of 62 (77.4%) of the children in this systematic review with sleep exclusive laryngomalacia were diagnosed after having failed adenotonsillectomy. Children with sleep exclusive laryngomalacia are typically diagnosed at an older age (around 2-12 years), with a few studies reporting the diagnosis in children under 2 years of age. On the other hand, congenital laryngomalacia, as the name implies, is identified soon after birth, and the children will classically present with stridor and respiratory difficulty. In all studies evaluating congenital laryngomalacia with OSA, flexible or awake laryngoscopy was used for diagnosis, and DISE was additionally performed in four of eight studies reporting supraglottoplasty outcomes.
Second, children with OSA and either sleep exclusive laryngomalacia or congenital laryngomalacia can have improvement in AHI after supraglottoplasty. In children with sleep exclusive laryngomalacia and OSA, supraglottoplasty decreased the AHI from a M 6 SD of 14.0 6 16.5 (95% CI 10.0, 18.0) to 3.3 6 4.0 (95% CI 2.4, 4.4), and when evaluating the SMD, the magnitude of effect was large (Cohen' 20 et al. reported a 0.5 point decrease in the LSAT in eight patients after supraglottoplasty-and why this occurred is unclear. For congenital laryngomalacia, the LSAT improved from a M 6 SD of 74.5 6 11.9% (95% CI 70.9, 78.1) to 88.4 6 6.6% (95% CI 86.4, 90.4), with the SMD demonstrating a large magnitude of effect. The most dramatic improvement in LSAT was reported in the study by Li et al., 67 who reported a 21.5 point improvement in LSAT after surgery, which is likely secondary to the study specifically selecting infants with severe laryngomalacia. Overall, supraglottoplasty improved the lowest oxygen saturation by 2.8 points in sleep exclusive laryngomalacia patients (Table  II) and by 13.9 points in congenital laryngomalacia patients (Table III) .
Fourth, when the subanalyses were performed by using random effects modeling to evaluate if there was a study or a group of studies that stood apart from the rest as having better or worse than expected outcomes, there was no study with significant differences for AHI in sleep exclusive laryngomalacia and only one study (O'Connor et al. 48 ), with significant differences for AHI in the congenital laryngomalacia patients. With regard to the LSAT, there was statistically significant heterogeneity and low inconsistency for sleep exclusive laryngomalacia studies and significant heterogeneity and high inconsistency among the congenital laryngomalacia studies. To find inconsistency and heterogeneity with regard to the lowest oxygen saturation in this meta-analysis is not surprising given that infants (i.e., Li et al. 67 ) generally have worse oxygen desaturation before surgery secondary to lower oxygen reserves as compared to older children (Chan (a) et al. 20 and Chan (b) et al.). 2 In children with congenital laryngomalacia, the literature demonstrates the additional benefit of improvement in daytime symptoms such as stridor, feeding difficulties, and failure to thrive.
Fifth, additional research is needed. The earliest study we identified reporting polysomnography outcomes was by Marcus et al. 47 in 1990; however, the study was excluded because some of the patients were sedated with chloral hydrate during the polysomnogram, and there was no individual patient data for those not sedated. All of the studies identified in the literature with quantitative polysomnographic data meeting inclusion criteria were published within the past decade. One study was level 5 evidence (case report), 11 studies were level 4 (case series), and one study was level 3 (case-control); there was no cohort and no randomized trial encountered in the literature. It should be pointed out that a major confounder is that patients with the most severe laryngomalacia may have significant obstruction (causing hypoxemia, cyanosis, acute life-threatening events, cor pulmonale, pulmonary hypertension, etc.); these patients generally undergo supraglottoplasty in a more urgent fashion, and in that case there may not be preand/or postoperative polysomnograms. Additionally, in considering patients with severe symptoms, it may not be possible to randomize them to either isolated supraglottoplasty or an observational control arm because the lack of an intervention may be unacceptable and unethical due to the risk of allowing ongoing, untreated severe obstructions, which can lead to repeated hypoxemia and associated complications. Therefore, if randomized trials were performed, they would likely include patients with mild to moderate disease. Additionally, in order to facilitate the use of a common language, we are recommending that common terminology be used by researchers. With regard to the type of patients included in the study, it should be clear whether the patients are those with congenital laryngomalacia, or if the patients are those with sleep exclusive laryngomalacia. It would be expected that patients with congenital laryngomalacia will present earlier given that they generally have more signs and symptoms than those who present when they are older children. With regard to outcomes data, if the ( ) represents the number of patients out of the total with the comorbidity; £ 5 study included congenital (2 patients) and sleep exclusive (1 patient). following variables were reported consistently and in a standardized fashion, it would significantly facilitate future research: 1) polysomnography scoring criteria used (e.g., 3% or 4% desaturations); 2) apnea-hypopnea index should be reported, this would should not preclude authors from reporting other indices (i.e., RDI); 3) oxygen saturation variables, such as: a) the overall mean oxygen saturation (M O2 sat), b) the oxygen desaturation index, c) the time (T) spent below specific oxygenation levels (i.e., 85% and 90% oxygen saturation [T < 85%] and [T < 90%], respectively), and d) lowest oxygen saturation); 4) details regarding the extent of surgery performed for the patients, with Ms and SDs; and 5) publication of the individual patient data when possible.
Limitations
As with any systematic review, it is possible that we missed studies in the literature despite our best efforts. Second, there may be differences in hypopnea scoring criteria between institutions; however, these differences were not specified by the articles in this review. Third, the studies were all retrospective in nature; therefore, the study authors were limited to the data available in the medical records.
CONCLUSION
Supraglottoplasty has improved AHI and LSAT in children with OSA and either sleep exclusive laryngomalacia or congenital laryngomalacia; however, the majority of them are not cured.
